- Home
- CVGW vs ARCT Comparison
CVGW vs ARCT Comparison
Compare CVGW & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVGW
- ARCT
- Stock Information
- Founded
- CVGW 1924
- ARCT 2013
- Country
- CVGW United States
- ARCT United States
- Employees
- CVGW N/A
- ARCT N/A
- Industry
- CVGW Specialty Foods
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CVGW Consumer Discretionary
- ARCT Health Care
- Exchange
- CVGW Nasdaq
- ARCT Nasdaq
- Market Cap
- CVGW 453.6M
- ARCT 487.0M
- IPO Year
- CVGW N/A
- ARCT N/A
- Fundamental
- Price
- CVGW $24.69
- ARCT $16.79
- Analyst Decision
- CVGW Buy
- ARCT Strong Buy
- Analyst Count
- CVGW 2
- ARCT 7
- Target Price
- CVGW $33.50
- ARCT $65.00
- AVG Volume (30 Days)
- CVGW 226.9K
- ARCT 400.9K
- Earning Date
- CVGW 01-14-2025
- ARCT 03-06-2025
- Dividend Yield
- CVGW 3.24%
- ARCT N/A
- EPS Growth
- CVGW N/A
- ARCT N/A
- EPS
- CVGW N/A
- ARCT N/A
- Revenue
- CVGW $661,544,000.00
- ARCT $160,399,000.00
- Revenue This Year
- CVGW N/A
- ARCT $7.33
- Revenue Next Year
- CVGW $3.27
- ARCT $4.71
- P/E Ratio
- CVGW $64.97
- ARCT N/A
- Revenue Growth
- CVGW 11.35
- ARCT N/A
- 52 Week Low
- CVGW $20.30
- ARCT $14.30
- 52 Week High
- CVGW $31.26
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- CVGW 47.75
- ARCT 46.15
- Support Level
- CVGW $22.00
- ARCT $16.07
- Resistance Level
- CVGW $25.88
- ARCT $17.95
- Average True Range (ATR)
- CVGW 0.89
- ARCT 1.36
- MACD
- CVGW 0.03
- ARCT -0.07
- Stochastic Oscillator
- CVGW 69.33
- ARCT 14.86
About CVGW Calavo Growers Inc.
Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.